[1]
|
Buie, M.J., Quan, J., Windsor, J.W., et al. (2023) Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review with Temporal Analyses. Clinical Gastroenterology and Hepatology, 21, 2211-2221. https://doi.org/10.1016/j.cgh.2022.06.030
|
[2]
|
Le Berre, C., Honap, S. and Peyrin-Biroulet, L. (2023) Ulcerative Colitis. The Lancet, 402, 571-584. https://doi.org/10.1016/S0140-6736(23)00966-2
|
[3]
|
Xu, L., He, B., Sun, Y. and Li, J. (2023) Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Population-Based Study. Clinical Gastroenterology and Hepatology.
|
[4]
|
Satsangi, J., Silverberg, M.S., Vermeire, S. and Colombel, J.F. (2006) The Montreal Classification of Inflammatory Bowel Disease: Controversies, Consensus, and Implications. Gut, 55, 749-753. https://doi.org/10.1136/gut.2005.082909
|
[5]
|
何美萍, 徐月. 蒙特利尔分型下溃疡性结肠炎急性期保留灌肠插管深度的探讨[J]. 中国中医急症, 2018, 27(4): 663-665.
|
[6]
|
宋孝美, 于劲, 史立伟, 等. 炎症性肠病内镜评分的临床应用及评价[J]. 中华炎性肠病杂志, 2023, 7(1): 2-6.
|
[7]
|
Xie, T., Zhang, T., Ding, C., et al. (2018) Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in Guiding the Need for Colectomy in Patients with Acute Severe Colitis. Gastroenterology Report (Oxford), 6, 38-44. https://doi.org/10.1093/gastro/gox016
|
[8]
|
Peyrin-Biroulet, L., Arenson, E., Rubin, D.T., et al. (2023) A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index. Journal of Crohn’s and Colitis, 17, 1733-1743. https://doi.org/10.1093/ecco-jcc/jjad087
|
[9]
|
Feagan, B.G., Chande, N. and MacDonald, J.K. (2013) Are There Any Differences in the Efficacy and Safety of Different Formulations of Oral 5-ASA Used Forinduction and Maintenance of Remission in Ulcerative Colitis Evidence from Cochrane Reviews. Inflammatory Bowel Diseases, 19, 2031-2040. https://doi.org/10.1097/MIB.0b013e3182920108
|
[10]
|
Kato, S., Ishibashi, A., Kani, K. and Yakabi, K. (2018) Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository. Digestion, 97, 59-63. https://doi.org/10.1159/000484224
|
[11]
|
Choi, Y.S., Kim, W.J., Kim, J.K., Kim, D.S. and Lee, D.H. (2018) Efficacy of Topical 5-Aminosalicylate Monotherapy in Patients with Ulcerativeproctitis with Skip Inflammation. Journal of Gastroenterology and Hepatology, 33, 1200-1206. https://doi.org/10.1111/jgh.14052
|
[12]
|
中华医学会消化病学分会炎症性肠病学组, 中国炎症性肠病诊疗质量控制评估中心. 中国溃疡性结肠炎诊治指南(2023年·西安) [J]. 中华炎性肠病杂志, 2024, 8(1): 33-58.
|
[13]
|
Singh, S. (2023) Positioning Therapies for the Management of Inflammatory Bowel Disease. Nature Reviews Gastroenterology & Hepatology, 20, 411-412. https://doi.org/10.1038/s41575-023-00744-9
|
[14]
|
Lynch, R.W., Lowe, D., Protheroe, A., Driscoll, R., Rhodes, J.M. and Arnott, I.D.R. (2013) Outcomes of Rescue Therapy in Acute Severe Ulcerativecolitis: Data from the United Kingdom Inflammatory Bowel Diseaseaudit. Alimentary Pharmacology & Therapeutics, 38, 935-945. https://doi.org/10.1111/apt.12473
|
[15]
|
Dai, N., Haidar, O., Askari, A. and Segal, J.P. (2022) Colectomy Rates in Ulcerativecolitis: A Systematic Review and Meta-Analysis. Digestive and Liver Disease, 55, 13-20. https://doi.org/10.1016/j.dld.2022.08.039
|
[16]
|
Vavricka, S.R., Schoepfer, A., Scharl, M., et al. (2015) Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 21, 1982-1992. https://doi.org/10.1097/MIB.0000000000000392
|
[17]
|
Fazio, V.W., Kiran, R.P., Remzi, F.H., et al. (2013) Ileal Pouch Anal Anastomosis: Analysis of Outcome and Quality of Life in 3707 Patients. Annals of Surgery, 257, 679-685. https://doi.org/10.1097/SLA.0b013e31827d99a2
|
[18]
|
蒋晓芸, 戎兰, 王悦之, 等. 炎症性肠病的肠外表现[J]. 中华消化杂志, 2007, 27(9): 628-629.
|
[19]
|
Kilic, Y., Kamal, S., Jaffar, F., Sriranganathan, D., Quraishi, M.N. and Segal, J.P. (2024) Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases, 30, 230-239. https://doi.org/10.1093/ibd/izad061
|
[20]
|
Alizadeh, M., Motwani, K., Siaton, B.C., et al. (2023) Factors Associated with Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad280
|
[21]
|
Barrie, A. and Regueiro, M. (2007) Biologic Therapy in the Management of Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 13, 1424-1429. https://doi.org/10.1002/ibd.20196
|
[22]
|
Greenstein, A.J., Janowitz, H.D. and Sachar, D.B. (1976) The Extra-Intestinal Complications of Crohn’s Disease and Ulcerative Colitis: A Study of 700 Patients. Medicine (Baltimore), 55, 401-412. https://doi.org/10.1097/00005792-197609000-00004
|
[23]
|
Tavarela Veloso, F. (2004) Review Article: Skin Complications Associated with Inflammatory Bowel Disease. Alimentary Pharmacology & Therapeutics, 20, 50-53. https://doi.org/10.1111/j.1365-2036.2004.02055.x
|
[24]
|
Wenzel, J., Gerdsen, R., Phillipp-Dormston, W., Bieber, T. and Uerlich, M. (2002) Topical Treatment of Pyoderma Gangraenosum. Dermatology, 205, 221-223. https://doi.org/10.1159/000065843
|
[25]
|
Brooklyn, T.N., Dunnill, M.G., Shetty, A., Bowden, J.J., Williams, J.D., Griffiths, C.E., Forbes, A., Greenwood, R. and Probert, C.S. (2006) Infliximab for the Treatment of Pyoderma Gangrenosum: A Randomised, Double Blind, Placebo Controlled Trial. Gut, 55, 505-509. https://doi.org/10.1136/gut.2005.074815
|
[26]
|
Hale, S. and Lightman, S. (2006) Anti-TNF Therapies in the Management of Acute and Chronic Uveitis. Cytokine, 33, 231-237. https://doi.org/10.1016/j.cyto.2005.12.012
|
[27]
|
Danese, S., Semeraro, S., Papa, A., Roberto, I., Scaldaferri, F., Fedeli, G., Gasbarrini, G. and Gasbarrini, A. (2005) Extraintestinal Manifestations in Inflammatory Bowel Disease. World Journal of Gastroenterology, 11, 7227-7236. https://doi.org/10.3748/wjg.v11.i46.7227
|
[28]
|
Loftus, E.V., Harewood, G.C., Loftus, C.G., Tremaine, W.J., Harmsen, W.S., Zinsmeister, A.R., Jewell, D.A. and Sandborn, W.J. (2005) PSC-IBD: A Unique Form of Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis. Gut, 54, 91-96. https://doi.org/10.1136/gut.2004.046615
|
[29]
|
Khademi, Z., Pourreza, S., Amjadifar, A., Torkizadeh, M. and Amirkhizi, F. (2024) Dietary Patterns and Risk of Inflammatory Bowel Disease: A Systematic Review of Observational Studies. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad297
|
[30]
|
Chicco, F., Magrì, S., Cingolani, A., et al. (2021) Multidimensional Impact of Mediterranean Diet on IBD Patients. Inflammatory Bowel Diseases, 27, 1-9. https://doi.org/10.1093/ibd/izaa097
|
[31]
|
Chiba, M., Tsuji, T., Nakane, K., et al. (2020) High Remission Rate with Infliximab and Plant-Based Diet as First-Line (IPF) Therapy for Severe Ulcerative Colitis: Single-Group Trial. The Permanente Journal, 24, 1-10. https://doi.org/10.7812/TPP/19.166
|
[32]
|
Barberio, B., Zamani, M., Black, C.J., Savarino, E.V. and Ford, A.C. (2021) Prevalence of Symptoms of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. The Lancet Gastroenterology and Hepatology, 6, 359-370. https://doi.org/10.1016/S2468-1253(21)00014-5
|
[33]
|
Nigro, G., Angelini, G., Grosso, S.B., Caula, G. and Sategna-Guidetti, C. (2001) Psychiatric Predictors of Noncompliance in Inflammatory Bowel Disease: Psychiatry and Compliance. Journal of Clinical Gastroenterology, 32, 66-68. https://doi.org/10.1097/00004836-200101000-00015
|
[34]
|
Moreira, F.P., Cardoso Tde, A., Mondin, T.C., et al. (2015) The Effect of Proinflammatory Cytokines in Cognitive Behavioral Therapy. Journal of Neuroimmunology, 285, 143-146. https://doi.org/10.1016/j.jneuroim.2015.06.004
|
[35]
|
Sciberras, M., Karmiris, K., Nascimento, C., et al. (2022) Mental Health, Work Presenteeism, and Exercise in Inflammatory Bowel Disease. Journal of Crohn’s and Colitis, 16, 1197-1201. https://doi.org/10.1093/ecco-jcc/jjac037
|
[36]
|
Milo, F., Imondi, C., D’Amore, C., et al. (2024) Short-Term Psychodynamic Psychotherapy in Addition to Standard Medical Therapy Increases Clinical Remission in Adolescents and Young Adults with Inflammatory Bowel Disease: A Randomised Controlled Trial. Journal of Crohn’s and Colitis, 18, 256-263. https://doi.org/10.1093/ecco-jcc/jjad145
|
[37]
|
Zand, A., Van Deen, W.K., D’Haens, G.R., et al. (2015) Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact. Inflammatory Bowel Diseases, 21, 1623-1630. https://doi.org/10.1097/MIB.0000000000000399
|
[38]
|
Jones, P.D., Kappelman, M.D., Martin, C.F., et al. (2015) Exercise Decreases Risk of Future Active Disease in Patients with Inflammatory Bowel Disease in Remission. Inflammatory Bowel Diseases, 21, 1063-1071. https://doi.org/10.1097/MIB.0000000000000333
|
[39]
|
周颖, 柳惠未. 运动在炎症性肠病患者辅助治疗中的研究进展[J]. 中华炎性肠病杂志, 2023, 7(4): 346-350.
|